XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule II. Condensed Financial Information of Registrant
12 Months Ended
Dec. 31, 2021
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]  
Schedule II. Condensed Financial Information of Registrant

Schedule II. Condensed Financial Information of Registrant

AMERISAFE, INC.

CONDENSED BALANCE SHEETS

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

 

(in thousands)

 

Assets:

 

 

 

 

 

 

 

 

Investments:

 

 

 

 

 

 

 

 

Fixed maturity securities—held-to-maturity, at amortized cost net of allowance

   for credit losses of $0 in 2021 and 2020,

   (fair value $0, and $361 in 2021 and 2020, respectively)

 

$

 

 

$

361

 

Fixed maturity securities—available-for-sale, at fair value

   (amortized cost $19,650 and $7,210 in 2021 and 2020, respectively)

 

 

19,605

 

 

 

7,259

 

Equity securities, at fair value (cost $10,007 in 2021 and 2020)

 

 

14,092

 

 

 

11,503

 

Short-term investments

 

 

55,559

 

 

 

9,676

 

Investment in subsidiaries

 

 

290,077

 

 

 

384,774

 

Total investments

 

 

379,333

 

 

 

413,573

 

Cash and cash equivalents

 

 

18,825

 

 

 

23,562

 

Deferred income taxes

 

 

1,148

 

 

 

 

Notes receivable from subsidiaries

 

 

2,275

 

 

 

2,140

 

Property and equipment, net

 

 

2,003

 

 

 

1,605

 

Federal income tax recoverable

 

 

857

 

 

 

2,705

 

Other assets

 

 

1,295

 

 

 

1,420

 

Total assets

 

$

405,736

 

 

$

445,005

 

Liabilities and shareholders’ equity

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

Accounts payable and other liabilities

 

 

6,413

 

 

 

6,095

 

Deferred income taxes

 

 

 

 

 

94

 

Total liabilities

 

 

6,413

 

 

 

6,189

 

Shareholders' equity (net of Treasury stock of $22,370 at December 31, 2021 and 2020)

 

 

399,323

 

 

 

438,816

 

Total liabilities and shareholders' equity

 

$

405,736

 

 

$

445,005

 

 

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF INCOME

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

$

896

 

 

$

944

 

 

$

915

 

Net unrealized gains (losses) on equity securities

 

 

2,590

 

 

 

(276

)

 

 

1,977

 

Fee and other income

 

 

8,541

 

 

 

9,122

 

 

 

5,352

 

Total revenues

 

 

12,027

 

 

 

9,790

 

 

 

8,244

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

Other operating costs

 

 

8,541

 

 

 

9,122

 

 

 

8,244

 

Total expenses

 

 

8,541

 

 

 

9,122

 

 

 

8,244

 

Income before income taxes and equity in earnings of subsidiaries

 

 

3,486

 

 

 

668

 

 

 

 

Income tax expense (benefit)

 

 

(1,188

)

 

 

259

 

 

 

376

 

Gain (loss) before equity in earnings of subsidiaries

 

 

4,674

 

 

 

409

 

 

 

(376

)

Equity in net income of subsidiaries

 

 

61,083

 

 

 

86,193

 

 

 

93,066

 

Net income

 

$

65,757

 

 

$

86,602

 

 

$

92,690

 

 

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF CASH FLOWS

 

  

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Operating activities

 

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

6,622

 

 

$

6,012

 

 

$

2,333

 

Investing activities

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of investments

 

 

(87,289

)

 

 

(10,982

)

 

 

(27,140

)

Proceeds from sales of investments

 

 

28,780

 

 

 

18,970

 

 

 

1,987

 

Purchases of property and equipment

 

 

(1,277

)

 

 

(764

)

 

 

(995

)

Dividends from subsidiary

 

 

148,400

 

 

 

88,600

 

 

 

115,900

 

Net cash provided by investing activities

 

 

88,614

 

 

 

95,824

 

 

 

89,752

 

Financing activities

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from stock option exercises

 

 

 

 

 

 

 

 

20

 

Finance lease purchases

 

 

(44

)

 

 

(50

)

 

 

(47

)

Dividends to shareholders

 

 

(99,929

)

 

 

(88,775

)

 

 

(87,016

)

Net cash used in financing activities

 

 

(99,973

)

 

 

(88,825

)

 

 

(87,043

)

Change in cash and cash equivalents

 

 

(4,737

)

 

 

13,011

 

 

 

5,042

 

Cash and cash equivalents at beginning of year

 

 

23,562

 

 

 

10,551

 

 

 

5,509

 

Cash and cash equivalents at end of year

 

$

18,825

 

 

$

23,562

 

 

$

10,551